A rare case of invasive mucormycosis with thrombosis of cerebral vasculature in diabetic ketoacidosis

Authors

  • Shahitha Sardar Department of General Medicine, Sri Venkateswaraa Medical College and Research Institute, Chennai, Tamil Nadu, India
  • Suseendhran Srinivasan Department of General Medicine, Sri Venkateswaraa Medical College and Research Institute, Chennai, Tamil Nadu, India
  • Samuthiravel Shanmugam Department of General Medicine, Sri Venkateswaraa Medical College and Research Institute, Chennai, Tamil Nadu, India
  • Jagadeesan Mohanan Department of General Medicine, Sri Venkateswaraa Medical College and Research Institute, Chennai, Tamil Nadu, India
  • Prasanna Karthik Suthakaran Department of General Medicine, Sri Venkateswaraa Medical College and Research Institute, Chennai, Tamil Nadu, India
  • Damodaran Jeyachandran Department of General Medicine, Sri Venkateswaraa Medical College and Research Institute, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20241637

Keywords:

Mucormycosis, Diabetes, Fungal infection

Abstract

Mucormycosis is a rare fungal infection. It is an aggressive angio invasive infection hence if left untreated is always fatal. This necrotising infection commonly involves the nose, paranasal sinuses, orbits and brain. Uncontrolled diabetes, immunosuppression, transplant recipients, COVID-19 infection are the commonest risk factors. Most common form is rhino orbital cerebral involvement. Antifungal agents along with surgical debridement is the mainstay of treatment. We are reporting such a case of invasive mucormycosis in a young diabetic male to stress the importance of clinical examination and early recognition of clinical signs of this rare invasive infection and aggressive management.

 

References

Paltauf A. Mycosis mucorina. Virchows Arch Pathol Anat Physiol Klin Med. 1885;102:543-64.

Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis. 2012;54(1):S8-15.

Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: Emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 2001;125:375-8.

Sugar AM. In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Fifth edition. Mandell GL, Bennett JE, Dolin R, editors. Churchill Livingstone; New York, USA. 2000.

Pandey M, Agarwal R, Dabas Y, Jyotsna V P, Kumar R, Immaculata X, et al, Emerging Rhizopus microsporus Infections in India. J Clin Microbial. 2018;56:1-5.

Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: An Update. J Fungi. 2020;6(4):265.

Al-Tarrah K, Abdelaty M, Behbahani A, Mokaddas E, Soliman H, Albader A. Cutaneous mucormycosis postcosmetic surgery: a case report and review of the literature. Medicine (Baltimore). 2016;95:e4185.

Lalwani J, Kumar L, Rameshwar, Jagadeesan M. A rare case of mucormycosis in heart transplantation. Int J Adv Med 2022;9:1143-5.

Rammaert B, Lanternier F, Kania R, Lortholary O. Diabetes and mucormycosis: a complex interplay. Diabetes Metabolism. 2012;38(3):193-204.

Bharathi SM, Prakash A, Prakasam KCA, Anbazhagan R. A Review: Mucormycosis. International Journal of All Research Education and Scientific Methods. 2021;9(8):1591-98.

Tedder M, Spratt JA, Anstadt MP, Hedge SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044-50.

Cohen SG, Greenberg MS. Rhinomaxillary mucormycosis in a kidney transplant patient. Oral Surg Oral Med Pathol. 1980;50:33-8.

Goh LC, Shakri ED, Ong HY, et al. A seven-year retrospective analysis of the clinicopathological and mycological manifestations of fungal rhinosinusitis in a single-centre tropical climate hospital. J Laryngol Otol. 2017;131:813-6.

Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-53.

Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L, et al. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Clin Microbiol Infect. 2012;18(10):E396-400.

Singla K, Samra T, Bhatia N. Primary cutaneous mucormycosis in a trauma patient with Morel-Lavallee lesion. Indian J Crit Care Med. 2018;22:375-7.

Dekkers R, Verweij PE, Weemaes CM, Severijnen RS, Van Krieken JH, Warris A. Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous disease. Med Mycol. 2008;46:491-4.

Kung VL, Chernock RD, Burnham CD. Diagnostic accuracy of fungal identification in histopathology and cytopathology specimens. Eur J Clin Microbiol Infect Dis. 2018;37:157-65.

Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 2001;125:375-8.

Marty FM, Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, et al. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species. Mycoses. 2018;61(7):485-97.

Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50(1):126-33.

Downloads

Published

2024-06-25

Issue

Section

Case Reports